RAF1 and lung cancer: In another study by Schuller and Cekanova, NNK is reported to stimulate β2-AR receptor pathway (including PKA, cAMP, CREB) and transactivate EGFR pathway (such as Raf-1/ERK1/2 signaling) in the development of lung cancer [53].